Increased expression of TLR4, which recognizes the lipopolysaccharide of bacteria, has been confirmed in IBD, and abnormal immune responses to intestinal bacteria are believed to be associated with the pathology of IBD15. The gene discussed is TLR4; the disease is inflammatory bowel disease.